Eprazinone dihydrochloride NEW
| Price | $30 | $46 |
| Package | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-02 |
Product Details
| Product Name: Eprazinone dihydrochloride | CAS No.: 10402-53-6 |
| Purity: 99.25% | Supply Ability: 10g |
| Release date: 2025/11/02 |
Product Introduction
Bioactivity
| Name | Eprazinone dihydrochloride |
| Description | Eprazinone dihydrochloride (NSC 317935) is a mucolytic with antitussive and mucolytic effect. |
| In vivo | Eprazinone 2HCl is a drug with proposed mucolytic, secretolytic, and bronchial antispasmodic properties. Eprazinone 2HCl improves pulmonary function and arterial pOO. Eprazinone also appears to have an antitussive and mucolytic effect. Eprazinone influences both bronchoalveolar lavage fluid (BAL) lipid levels and ion transport. [1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 1 mg/mL (2.21 mM), Sonication is recommended. H2O : 14.3 mg/mL (31.54 mM), Sonication is recommended. |
| Keywords | transport | Tachykinin receptor | secretolytic | pulmonary | pO2 | Phospholipid | NSC-317935 | NSC317935 | NK1R | NK receptor | Neurokininreceptor | Neurokinin Receptor | Neurokinin receptor | mucolytic | Inhibitor | inhibit | Eprazinone dihydrochloride | Eprazinone Dihydrochloride | Eprazinone | chloride | arterial | antitussive | antispasmodic |
| Inhibitors Related | Maropitant citrate | Rolapitant | Ezlopitant | (R)-CJ 11974 | N-Acetyl-L-tryptophan | Netupitant | Aprepitant | Vofopitant dihydrochloride | Befetupitant | Vofopitant | Fosaprepitant dimeglumine | Maropitant |
| Related Compound Libraries | Bioactive Compound Library | Neuronal Signaling Compound Library | Approved Drug Library | Membrane Protein-targeted Compound Library | Anti-Obesity Compound Library | Drug Repurposing Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bitter Compound library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1kg |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-05-07 | |
| $1520.00/25mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 | |
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-06-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY